Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | 1-Methylpiperazine | HCID 53167 | — |
| Reactant | Sodium Bicarbonate | HCID 516892 | — |
| Reactant | 1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine) | HCID 636044 | — |
| Reactant | HCID 68690037 | HCID 68690037 | — |
| Catalyst | (1E,4E)-1,5-diphenylpenta-1,4-dien-3-one; palladium | HCID 6505921 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Toluene | HCID 1140 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 68685955 | HCID 68685955 | — |
Reaction Steps
The mixture of 17 mg of N-[5-bromo-4-(8-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]-N-[(1S)-1-phenylethyl]acetamide [16-1], 2.17 mg of bis(dibenzylideneacetone)palladium, 19 mg of 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene, 17.2 mg of cesium carbonate, 5.0 μL of 1-methylpiperazine, 0.25 mL of toluene, and 0.5 mL of 1,4-dioxane, was stirred at 80° C. for 3 days. After cooling the reaction mixture back to room temperature, a saturated aqueous solution of sodium hydrogen carbonate and water were added thereto, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, and then dried over anhydrous sodium sulfate. The insolubles were filtered, the filtrate was concentrated under reduced pressure, and the residue was purified by preparative reversed phase liquid chromatography, to obtain 0.6 mg of N-[4-(8-methylimidazo[1,2-a]pyridin-3-yl)-5-(4-methyl-1-piperazinyl)-2-pyrimidinyl]-N-[(1S)-1-phenylethyl]acetamide [16-2].
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07718801B2 |
|---|
| Source dataset | uspto-grants-2010_05 |
|---|
| ORD ID | ord-1ce4819ae3b94a398cf930dbafe03e82 |
|---|
| Source note | uspto-grants-2010_05 |
|---|